Q&A

A new blood test may soon allow clinicians to diagnose brain tumors without surgical biopsy

Historically, women were excluded from some clinical trials because of the exact things that we now want to understand

Matthew M. Laughon, MD, MPH is a professor at the University of North Carolina (UNC) at Chapel Hill in the
department of pediatrics.

New technologies are allowing physicians to make timely decisions for cancer patients

A conversation with Dara Wright, executive vice president and president of the clinical diagnostics group at Bio-Rad

Clinical Lab Manager talks with Sandrine Miller-Montgomery, PharmD, PhD, about microbiome research and its applications in cancer research

A conversation with Dave Hickey, worldwide president of integrated diagnostic solutions at BD

Rapid and early detection of SARS-CoV-2 plays a crucial role in facilitating early intervention and treatment and preventing disease spread

Clinical Lab 2.0 is a movement that provokes the lab industry to view itself through a new value lens aligned with the forces driving the future of value-based health care

Going automated can be a lengthy process, but patients ultimately benefit

Antibiotic stewardship should be a priority for all patient-facing clinicians

How healthcare is primed for disruption

A conversation with Janice Chen, PhD, the co-founder and chief research officer of Mammoth Biosciences

A conversation with Maximilian Diehn, MD, PhD, associate professor of radiation oncology at  Stanford University

A conversation with Megan Allyse, PhD, assistant professor of biomedical ethics at Mayo Clinic

Anthony Atala, MD, discusses some of the exciting possibilities as well as existing challenges in 3-D bioprinting

Going automated can be a lengthy process, but patients ultimately benefit

George Miles, MD, PhD shares some details on his work in clinical genomics